Literature DB >> 7204978

The third component of complement inhibits human lymphocyte blastogenesis.

B W Needleman, J M Weiler, T L Feldbush.   

Abstract

Purified human C3 was studied for its ability to regulate human peripheral blood lymphocyte activation in a serum-free tissue culture system. C3 and its fragments formed by trypsin digestion were not mitogenic. However, C3 inhibited both mitogen- and antigen-induced lymphocyte proliferation in a dose-related manner. The observed inhibition by C3 increased with an increase in the dose of mitogen, with 50% inhibition seen at a C3 dose of 2.5 to 25 microgram/ml. Inhibition was induced even when C3 was added at 69 hr in a 99-hr culture, suggesting an effect on late events in activation. The inhibition was not mediated through generalized cytotoxicity, was not an artifact of kinetic alteration and still occurred in macrophage-depleted cultures. A small m.w. fragment of C3 which contained the inhibitory capacity in our C3 preparation was similar to C3a in size, anaphylatoxin activity, heat and acid stability and inhibition by serum. Our results indicate that cleavage products by C3 may play a negative role in lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.

Authors:  T Kajita; T E Hugli
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.

Authors:  M Kings; U E Nydegger; A L de Weck
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

3.  Influence of monoclonal anti-Ia like antibodies on activation of human lymphocytes.

Authors:  C M Steel; V Van Heyningen; K Guy; B B Cohen; D L Deane
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

Review 4.  The role of complement in the induction and regulation of immune responses.

Authors:  T G Egwang; A D Befus
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

Review 5.  Regulation of immune response by components of the complement cascade and their activated fragments.

Authors:  W O Weigle; M G Goodman; E L Morgan; T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1983

6.  Inhibition of human lymphocyte blastogenesis by C3: the role of serum in the tissue culture medium.

Authors:  J M Weiler; Z K Ballas; T L Feldbush; B W Needleman
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

7.  The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.

Authors:  K Yoshida; Y Yukiyama; S Hirose; T Miyamoto
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Modulation of human lymphocyte function by C3a and C3a(70-77).

Authors:  D G Payan; D E Trentham; E J Goetzl
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

9.  Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.

Authors:  E L Morgan; W O Weigle; T E Hugli
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.